Eilean Therapeutics

Eilean Therapeutics is a small-molecule oncology drug research and development company dedicated to improving the lives of cancer patients by conquering cancer. Many cancers develop resistance to treatment through mutations or escape mechanisms, which limits the efficacy of current therapies. The company has developed differentiated small molecules targeting fundamental biological pathways involved in drug resistance mutations and escape mechanisms in hematologic malignancies. By developing pan-variant therapies that address the primary drivers of cancer resistance, Eilean Therapeutics overcomes the limitations of current oncology treatments and advances the development of best-in-class therapeutics for hematologic malignancies.